In severe COVID-19, adding lopinavir-ritonavir to usual care did not improve mortality at 28 days.
Ann Intern Med
; 174(1): JC3, 2021 01.
Article
in English
| MEDLINE | ID: covidwho-1518748
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Ritonavir
/
Lopinavir
/
COVID-19 Drug Treatment
/
Hospitalization
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Limits:
Aged
/
Female
/
Humans
/
Male
Country/Region as subject:
Europa
Language:
English
Journal:
Ann Intern Med
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS